Crow Point Partners’s Zimmer Biomet ZBH Stock Holding History

Crow Point Partners’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q3	$481K	Buy	+5,275	New	+$529K	0.07%	109

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Crow Point Partners's ZBH Position: Q3 2015 in Review

Crow Point Partners opened a new position in Zimmer Biomet (ZBH) in Q3 2015: 5,275 shares worth $481K. The stake represents 0.07% of the portfolio and ranks #109 among its holdings.

725 funds tracked by Wall St. Rank hold ZBH as of Q3 2015.

Crow Point Partners held 5,275 shares of Zimmer Biomet worth $481K as of Q3 2015.
Zimmer Biomet was a new Crow Point Partners position in Q3 2015.
Zimmer Biomet made up 0.07% of Crow Point Partners's portfolio in Q3 2015, its #109 holding.
725 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2015.

Based on Crow Point Partners's 13F filing for Q3 2015, filed 17 Dec 2015.